Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Here's a summary of the Analyst Coverage for anyone who missed it. (12$ PT)
Paysign: An Emerging, Rapidly-Growing Niche Participant in FinTech; PT $12.00
Prepaid Card Market: Although prepaid cards are already in broad use across many
industry verticals, growth is expected to continue at an impressive rate. Data from
the Federal Reserve suggests that prepaid card transaction volumes will grow steadily
through 2022, reaching a market value of nearly $400 billion. A separate forecast from
ResearchAndMarkets.com estimates that this market (in the U.S. alone) should grow at
roughly 12%, annually through 2023, reaching a total market size $897 billion in 2023.
Paysign, Inc. is an emerging participant in the prepaid card space with impressive growth
potential. As such, we are initiating coverage with a Buy rating and $12.00 price target.
The PaySignTM Platform: As a participant in the prepaid card space, Paysign offers
vertically integrated payment processing and prepaid card programs and provides
innovative payment solutions to corporations, government agencies, universities,
healthcare entities, and other organizations. These payment solutions are adapted by
Paysign clients to drive customer loyalty and brand recognition, reward customers,
reduce administration costs and streamline operations.
Plasma Donor Payment Market: Plasma contains a composite of more than 700
proteins including clotting factor, albumin and immunoglobulin that are currently in wide
use as treatments for life-threatening conditions. Demand is high for these plasma
proteins (and related therapies) and the worldwide market has grown to a projected value
of $25.4 billion in 2019 with an expected 6.6% annual growth rate through 2024. The
US now supplies nearly two-thirds of all the blood plasma available in the world primarily
collected through a network of roughly 700 collection centers. Paysign currently owns
about one-third of the market for compensating plasma donors.
Earnings Model: Paysign generated revenues of $23.4 million in 2018—a jump of
53.8% year/year. We anticipate this type of growth to continue in 2019 as Q1 2019 was
quite impressive with revenues at $7.3MM, up 55% year/year. Guidance is for revenues
to approach $38 to $40 million for 2019, a projected growth rated of roughly 65%.
The bottom line is growing even faster as we forecast non-GAAP net income to reach
$11.6MM for calendar 2019, an increase of 130% on a year-over-year basis. For 2020 we
estimate revenues of $61 million and non-GAAP cash earning of $23.2 million or $0.48
per share.
Our Outlook: With an impressive start to the year (Q1 revenues up 55% y/y) we believe
Paysign's current market valuation is not reflective of the value of the company’s growing
presence in the prepaid card space. Given the expected revenue growth and the future
earnings potential, we believe the company should be valued more in line with its current
and potential earnings growth and other successful companies in the payments/business
services space. We estimate that in calendar 2019 Paysign is likely to continue to expand
its presence in the prepaid card space through the addition of more plasma centers,
a significant move into the prescription co-pay segment and the launch of its PaySign
Premier Card. With these and other initiatives, we estimate revenues will climb to $39.0
million in 2019 and climb another 57% to $61.0 million in calendar 2020, with non-GAAP
cash earnings of $23.2 million or $0.48 per share. Given this expected performance we
believe a fair valuation would be a 30x multiple on our estimated 2020 non-GAAP cash
earnings per share of $0.48. Discounting this number back to the present at 20% equates
to a fair value and our price target of $12.00.
I was able to swing it so I’ll be there.
Updated Analyst Coverage Comments:
Seems to be a little of "sell the news" going on as I feel there was lots of buying the rumor prior to this. Nevertheless, results were great! Strong top line growth, great uptick in Gross margins and EBITDA climbing nicely as the Company starts to realize economies of scale and doesn't have to increase SG&A as much to support top line growth. Big things to come with the GPR card - Share price needed a pause (and for some reason always seems to do this after blowout earnings).
Hope to see many of you at the shareholder meeting - After all, my schedule ended up working perfectly to slide it in as I was close by for a conference the day before.
See below updated commentary from analysts.
Maxim Group:
• 1Q19 results beat or matched consensus, and management reiterated 2019
guidance, which would represent a y/y increase in revenue of 62%-71% and a y/y increase in adjusted EBITDA of 104%-145%.
• The gross profit margin increased linked-quarter due to a mix shift in lines of business. We expect further increases.
• We maintain our price target at $10, which equates to a 2020 EV/revenue multiple of 7.1x, representing a 31% premium to the average of the two most relevant comparables. We regard this premium as warranted given PAYS’ high growth potential relative to these peers: average estimated peer revenue growth of 8% in 2020, versus 72% for PAYS.
BTIG:
Paysign, Inc. (PAYS) – until recently known as 3PEA International – had a high bar to clear as its 1Q19 earnings report approached given the stock’s surge of almost 141% since the beginning of the year. PAYS cleared that hurdle to the extent that it could, reporting 1Q19 beats on all relevant metrics: revenue, gross margin, adjusted earnings per share and adjusted EBITDA.
We are reiterating our Buy recommendation on PAYS and our price
target of $9.50 based on 19x the company’s FY21E EBITDA of
$25.1mm. We continue to believe PAYS’ combination of rapid revenue
growth, driven by both its core plasma donation prepaid debit card
business and its emerging pharma copay business, and its expanding
margins merit a premium multiple for the stock
Same idea as me.
Not a bad choice to do covered calls for a small portion of your position at 10$ - does limit your upside to 10$ but provides income via the calls premium. If it doesn't reach 10$ by June for example you keep the premium and your shares and can rinse repeat for extra income. I would like the 12.5$ strike to open up so its not limiting as much of the upside.
E.
Name change to PaySign Inc for those who didn’t see it in the recent fillings. Better alignment with their financial solutions brand (already being marketed as Pay Sign) and IMO is more descriptive of what they do and better for market awareness.
E.
BTIG bumped their target to 9.50$/share
Thanks Chilar, I’ve registered I’ll be flying out on a business trip shortly but hopefully will be free to Dial-in.
Looking forward to seeing the results!
E.
Just a reminder for all of you with lots of shares.
To prevent your shares from being shorted put your shares up for sale at a very high price ex; sell price limit order at 99$ (GTC) so they cannot be lent out by your broker. I find this especially useful given we now have lots of flippers around us and many various types of investors that are trying to make a buck shorting 3Pea.
Analyst Reports (BTIG:$8 Target & Maxim Group: $9 Target)
For those who didn't see it i've included snippets of the recent analyst upgrades further below:
BTIG (Upgraded to 8$):
TPNL Unveils Guidance for 2019 Revenue Growth of
63% to 72%; Reiterating Buy, Raising PT to $8
We are reiterating our Buy recommendation on 3Pea International
(TPNL) and raising our price target to $8 (from $6) based on 16x the
company’s FY21E adjusted EBITDA of $23.2mm after the company this
morning announced 2019 revenue guidance of $38mm to $40mm,
representing an increase of 63% to 72% versus the prior year. This would
represent a significant acceleration from TPNL’s revenue growth CAGR of
39% since 2015.
- Management further stated that they expected to see continued
improvement in TPNL’s gross margin in 2019 – it was 52.6% in 3Q18 –
thanks to operational improvements and a favorable product mix.
- We had initiated coverage of TPNL yesterday after the market close
with a price target of $6 that was predicated in part on our view that
the company would generate $30.9mm in revenue during 2019 that
would represent a year-over-year increase of almost 33%. We believed
that most of that revenue would be derived from TPNL’s core plasma
donation prepaid debit card business while also flagging the
company’s copay pharma initiative and launch of a general purpose
reloadable (GPR) debit card as potential sources of upside.
- CEO Mark Newcomer explained in the news release announcing
TPNL’s 2019 guidance this morning that the company during 2018 had
successfully entered new verticals, the impact of which would be seen
in its 2019 operating results. Management told us that their 2019
guidance reflected a significant contribution from TPNL’s pharma
copay business during the year, which we had viewed as a source of
optionality and had not been incorporated into our estimates.
- In addition to providing 2019 revenue guidance, management this
morning reaffirmed their guidance provided in November for 2018
revenue in a range of $22.75mm to $23.75mm and adjusted EBITDA in
a range of $4.8mm to $5.3mm.
- Valuation: Our price target of $8 for TPNL is based on 16x the
company’s FY21E EBITDA of $23.2mm.
Maxim Group (Upgraded to 9$):
Thesis: 3PEA's established plasma donor line of business should provide a reliable revenue stream that limits downside and helps fund upside/new initiatives, the most promising of which is general purpose reloadable cards.
Highlights include:
- Good product mix (1) plasma donor payments (3PEA partners
with plasma donor centers to pay donors); (2) pharmaceutical co-pay assistance (3PEA partners with pharmaceutical companies which are launching new drugs to pay for the amount of the patient co-pay for the drug); (3) other corporate incentive/ rewards programs; and (4) general purpose reloadable (GPR) cards)
- GPRs have the most potential and they expect 3PEA to be successful with GPR cards for two main reasons: (1) it already has an established base of more than 2 million cardholders to whom it can offer/cross-sell GPR cards; and (2) 3PEA Chairman Dan Henry is the former CEO of one of the two largest providers of GPR card programs.
Yep good idea - I've unpinned the one I had up there. I'll look to Chilar to unpin the other.
When I find spare time over the next week i'll put up a new one with updated info.
E.
BTIG Initiates Coverage Today with a 6$ price Target.
Also as an FYI - Essex Investment Management Co. LLC reported they bought 240,346 shares (reporting date was today but could have been bought a few days ago).
Good things to come!
E.
Hey Mermelstein,
Quite the opposite about the CFO. Brian did not actually step down in the same sense as you are thinking (and I know this for a fact). Brian was great (and still is) he stepped into the interim CFO role after they got rid of the other CFO back in 2014 (that was back when the PSKW settlement occurred).. he eventually stepped into the CFO role full time all while continuing lots of his other tasks as the company was still quite small. He knew the day would come when they would get a new CFO who would be fit for taking the company to the next level and the current one does just that with lots of great M&A experience and Brian went back to a role of VP corporate Finance.
I think we have a great team of executives that are incentivized to grow 3Pea, many of which have lots of experience within the industry and making other companies a success. Though, there might be other older shareholders and historical executives that may still own shares from the old days at a marginal average cost who may be looking to transfer them to new owners (likely block transfers to institutional hands or to current executives imo). Anyways that’s my take and opinion, I don’t blame historical holders for selling some shares, we don’t know their situation (could be old age, wealth diversification, money for another business venture, divorce, taxes, etc... trust me, as being someone who works in private equity and buys business from owners I’ve seen many reasons for ppl divesting their position while someone else like me sees the long term view/potential and buys it (similar to the buyer of the 1M shares on Friday).
Hope this helps!
E.
After Hour trading is typically done using electronic communication networks (ECNs) that match potential buyers and sellers without using a traditional stock exchange.
An ECN not only allows individual investors to interact electronically but also lets large institutional investors interact anonymously, thereby hiding their actions.
I presume its a way to mask who is exchanging the shares - maybe an institution buying the shares from an ex-exec or a major shareholder. Not sure but for every seller there is a buyer so someone just bought 1M shares... (they must have conviction)
From what I read it looks as though the new CFO will be going over the revised Investor Powerpoint deck in more detail (the new one on their website).
It looks as though the company is finally starting to tell "its story" to the investment community re; their proven track record of growth, their new product (reloadable cards), the future growth aspirations/new market verticals, etc... I've been trying for years to get management to spread the word though it seems we didn't need much of that to get us to where we are. The company is now turning into a larger entity and is professionalizing itself via an upgraded management Team/BOD (done), Up-listing to a reputable exchange (done), scheduling webcast and likely conference calls post-earnings with Q&A (in progress), gaining scale with organic growth & acquisitions (in progress).
The Company has come a long way from when I first invested in 2013 (and I'm sure that's applicable to many of us) - looking forward to following the company's progress in the years to come. I will be attending the webcast and will likely participate in the Q&A. Hope some of you will also join me.
E.
Updated Investor Presentation Posted
https://3pea.com/wp-content/uploads/2019/01/3PEA-Investor-Presentation_Jan-2019.pdf
Looks pretty good! Very nice professionalization of the business over the last few years.
Happy New Year to you too Mr. D and wishing to everyone on this board (and to management) a prosperous 2019! I’m sure 3PEA will help with that
Cheers,
E.
Maxim Group initiates coverage on 3Pea with a "Buy" rating and 5$ price target.
Nice to see some coverage starting!
E.
I can see revenue substantially increasing with the re-loadable cards.
For one, revenue coming from these new cards is substantially higher than 3 Pea's typical prepaid cards (they get revenue from people loading money to them and get money from the additional transactions occurring with these cards).
Also, customer acquisition costs will be low as 3Pea can simply convert lots of its client base from their traditional prepaid cards to general re loadable ones (for example every time someone calls into their call center they can introduce them to the new card and swap them)
Furthermore, this doesn't even include new verticals that the company can go after with these new cards (but obviously the easiest thing is going after its current clients).
We will only start seeing the full benefits of this next year but I expect much more upside to come for TPNL!
Just flying out on a business trip but saw the earnings release and had to comment. What a great quarter! Revenue growth of ~60% is surpassing my expectations, not to mention a consistent increase to the bottom line with adjusted EBITDA for the last 9 months of 3.5M trending towards 5M by year end. With growth rates continuing to trend over 50% for the foreseeable future we should definitely continue to trade at a meaningful premium - investors will seek high growth companies with strong earnings and we definitely fit the bill (not to mention a chart which looks great on the technical side). The one thing that really caught my eye and that is truly meaningful (which the company casually slipped in their update) was the launch of general reloadable cards. 3peas current card base is not general reloadable and the incremental earnings that could come from this are substantial (3pea would get revenue for every transaction made and all the money reloaded to the cards). Not too mention the company has over 2 million card holders right now which it could leverage for cross selling of these new cards (very low customer acquisition costs).
Anyways, the future looks bright for 3Pea I’m sure we will continue to be very happy campers for the foreseeable future! GLTA
WOW23P I found a few small firms covering OTIV (Lake Street Capital 2.50$ PT; Northland 2.50$ PT and Taglich Brothers $1.50 PT)
Had a spare second so looked them up and did some digging.
High-Level thoughts:
- Decent turnaround story/reasonable value at this price if they can continue to execute, they are doing a good job trimming costs (SG&A has been substantially trimmed over the years).
- Revenue growth (especially recurring revenue is finally starting to grow but not at a high pace)
- Looks like the next few quarters/2019 is expected to show positive EBITDA
- Not much debt on the balance sheet, and reasonable Working capital on hand.
- The Management Team does not have much skin in the game (1% of shares quite low - was 0one of the reasons I loved TPNL...)
Anyways worth throwing a little pocket change in it IMO.
Cheers,
E.
I’ll have to agree with you that when looking at correlation with WTI the US nanes so far better not to mention the ridiculous politics that disincentives oil investment and prevents Canadian oil companies from getting their oil to market at reasonable prices (given tons of delays and opposition to pipelines). Given most of my money is in CAD I tend to have to invest it there especially when our exchange rate is so poor vs. the US (but 3Pea has definitely substantially bumped up my US allocation not too shabby given I transferred that money to TPNL when the CAD/USD were at parity. I think DNR is reasonable play for oil but don’t mind CPG at the current price especially given Canadian oil prices (spread to WTI) is expected to improve to to an uptick in refinery capacity and increased capacity for shipping oil by rail coming into 2019. Let’s just hope trump can agree to a trade agreement with China and not impose any further tariffs or else oil will continue to take a hit as they are the ones driving most of the oil demand, thought I do think we will get back into inventory draws shortly as we go into winter and refinineries come back online which should help.
I am with you, the drop in many oil companies is well overdone. (I'm accumulating some of the Canadian guys that are now lower than when WTI fell to 27$, some of them have extremely good yields and have payout ratios below 100%, hedges at higher oil prices and Strong reserves but its an environment where investors have thrown the baby out with the bath water).
Apologies for being MIA, work and other side projects have been keeping me running on all cylinders! I'm still holding a decent chunk of TPNL and will be in for the long term, I can see the market rewarding us for high growth (which I expect to see via the Q3 results) especially at a time where growth is slowing down (albeit still growing at a good pace) and that many tech companies are being punished for not hitting the expected high growth rates.
I have not found any decent "value" plays like TPNL was back in the day but I will have to do a screening some time soon and will let you know if I find anything. I'm currently going long on a few oil plays, and have a few micro caps (but on the TSX so they would not be of too much interest to you! PDDPF is the pink sheets ticker of one of my TSXV plays but its a long term one)
Good luck!
Janey/Mr D, I live in Canada and since it’s been legalized here everyone has the right to grow 4 plants of their own for personal use. There’s been quite the hype over this cannabis sector, valuations are stretched for companies that have little revenue and are far away from making profits. To Chillar’s comment, I wouldn’t buy anything that is advertised on stockhouse, typically pump and dumps/overhyped (especially in the Cannabis sector). I’d rather find stocks the old fashion way through screeners and research (and for the share price to appreciate gradually based on its own merits like TPNL)
Similar to marginability (some trading houses may still not offer margin due to the high volatility and still small size/liquidity of the company), there is discretion when it comes to having options available for trading. It would have to trade above at this level for awhile and there would have to be enough of a market for it via liquidity (supply & demand) IMO will be still be a little while before this occurs but who knows...
We will definitely need a blockbuster Q3 with some strong guidance (which I anticipate will occur) to keep us up at this level /trending higher.
E.
Sorry guys, been MIA - as Chillar said been quite busy on my end just came back from a diligence trip in South America... I honestly can't wrap my head around what is driving this higher, I've looked everywhere. It is persistent accumulation (it has literally surpassed moving avg volume for everyday in the past week!) and no its not me or anyone affiliated. I have not bought any shares since the high 1$'s.
I personally can't value this on any present metrics as its getting quite up there... though whoever is buying is basing their thesis on future potential (as in the LT potential many years from now). I'm sure there is substantial top line growth (from current card solutions, and new verticals which i'm sure D. Henry will help!, not to mention margin enhancements, and likely a stabilized SG&A which will contribute to the bottom line; and just positive "guilt by association" from the impressive new hard hitting board of directors). Maybe a buyout? A major investor? just think if a larger company could process their own payments the margins that could be gained? Or alternatively if 3Pea bought another company who currently doesn't process their own payments the synergies that could be gained...
Anyways best of luck!
Also - if this stays above 5, brokers may start allowing margin on it and major institutions will now be able to buy it (as many have a min of 5$ for investing).
Hey chilar,
Things are definitely very busy on my end, I’ll see if I can put something together in the next month. I have a feeling others will start covering the stock/might write about it soon now that we are on the NASDAQ and have been showing great earnings.
E.
Great comment Mr. D,
I remember those GFRE days quite well (one of my first “home runners” back in the day luckily getting out before the whole China fraud reverse merger scandal/crash). We’ve come a long way with 3pea, it’s hard to imagine the days when this was just a stranded little 20 cent stock that would go days without any shares traded. This has been one of the better IH board with a small tight community that has been patiently following the company’s progress for years. The story is far from finished but we have definitely been/will be the shareholders that have gained the most and caught this company from its earliest days.
Glta,
E.
updated last message - wrote it quickly on my commute to work!
Great way to make an entrance on The Nasdaq tomorrow with stellar earnings today!
Have not had time to do a thorough analysis of it but at first glance it looks great. Better than expected top line growth at 60%, significant ramp up in gross margins from 44% to 48% and as a result EBITDA is trending nicely higher. It will be hard to find another Company growing at these 40-60% growth rates and I believe it will be in high demand once it’s on the Nasdaq.
This could be the start of something bigger as the company looks to do a small tuck in acquisition to expand capabilities and sector breadth.
Best of luck today, an exciting period to be a 3PEA holder!
E.
New research out on 3Pea with a 5$+/share target.
Link below:
https://static1.squarespace.com/static/5aaacb57506fbe4636414126/t/5b57be682b6a288bcafecda0/1532477033757/Alta+Fox+TPNL+Long+Idea+7.24.18.pdf
Big Bid coming in this morning at 2.49 for 52,300
REAL-TIME LEVEL 2 QUOTE
MPID BID PRICE SIZE TIME
CDEL 2.49 52,300 10:13
VERT 2.41 100 09:38
ETRF 2.40 535 09:39
VNDM 2.40 100 07/19
CSTI 2.40 100 09:30
CANT 2.37 100 08:30
NITE 0.244 2,500 09:40
MAXM 0.001 10,000 07:35
BGCE U 0 01/10
OTCX U 0 10:01
MPID ASK PRICE SIZE TIME
NITE 2.50 520 09:30
CSTI 2.50 100 08:30
VERT 2.51 100 10:13
ETRF 2.60 846 09:30
CANT 2.64 300 09:30
CDEL 2.66 1,000 10:13
VNDM 5.97 100 07/19
MAXM 200.00 1 07:35
BGCE U 0 01/10
OTCX U 0 09:40
Been an amazing run!
I personally didn’t think we would get here so fast. For that reason and given there was no concrete plan to uplist I was being extra conservative for the lack of liquidity and the fact we were so “under the radar”. I will have to redo my analysis with a bit less conservatism. I do think that given current earnings we are getting close to fair value but that’s not what people are paying for. People are paying for future earnings potential which could be substantial given higher than average annual growth rate, immense market opportunity and strong new board members that have a history of building billion dollar companies. For this reason, I think we could easily keep running and trade at a premium multiple. The trend is your friend and people will jump on the momentum and ride it upwards we can easily over extend to the upside and top 3$ if this continues and if the company continues to show high growth earnings (we will await Q2 and now there will be more eyes on us).
Anyways that’s my opinion, we are fortunate to have gotten in at the bottom floor of this one which could become something much bigger than we all thought. Have a great weekend!
E.
Nice car! I’ll consider getting one when I start have kids lol
Thanks for the mention ASP!
I didn't realize I was holding 3Pea for that long until I looked up the date of that older article I had written.
We have come a long way since then.
E.
I think your last post was more meant for today!
We broke out pretty hard...
New 3Pea Article by SC Capital:
https://seekingalpha.com/article/4176361-3pea-payment-processor-40-percent-organic-growth-selling-half-peer-multiples
Updated 2018FY Target Valuation - May 2018:
Q1-18 Overview:
Q1-18 was off to a great start (typically a slower quarter), the Company came out with a bang with revenue growing 46% over Q1-17 and I was especially happy to see gross margins substantially increase to 48% from 43% in Q1-17. The margin increase and sales increase ended up making up for a large portion of the SG&A bump up and kept the company increasing its net income over Q1-17 (and positioning it with some pretty substantial hires to help build the momentum over the remainder of the year). I expect the Company to continue this momentum going into the second half of the year and to start attracting more investors as people start noticing the high growth and up-listing prospects. (people will pay for growth and an acquirer would pay up for 3Pea's fully integrated payment processing capabilities so things are looking quite bright going forward).
You will find below my updated forecast for 3Pea's 2018FYE and the assigned valuation based on 3 different types of multiples.
2018 Financial Forecast:
Revenue: (46% growth) ~22.24M ** Increased to 46% based on Q1
Gross margins: 49% ~11.34M ** Increased to 49% as Q1 was 48% with expectation for more higher margin products to come in later in the year.
SG&A as a % of revenue 30% ~ 6.67M **increased from 26% to 30% as higher personnel costs have hit the books in Q1 but should stabilize over the rest of the year.
D&A and other: ~1M
EBITDA:4.22M
NI: 3.22M
F.d. share Count: ~47M
EPS: 0.07
Cash balance: ~5M (assumes we add another 2.9M this year)
LT debt:0$
**all multiples come from S&P capital IQ from companies in a similar industry - excluded larger entities that skew results to remain conservative.
Method 1 - EV/Sales:
EV/Sales Multiple:5.7x
Equity Value of ~131M
Share Value: 2.80$
Method 2 - EV/EBITDA:
EV/EBITDA Multiple:17.5x
Equity Value of 73.85M - Share Value: 1.68$
Method 3 - P/E:
P/E Multiple: 31.9x
Share Value: 2.19$
The average of the above methods gives us 2.22$/share.
Based on my analysis, it is well within reach for the Company to trade upwards of 2$/share. This is especially true with their new board members, and the potential uplist which should attract more investors and increase liquidity.
Best of luck!
E.
Was in Vegas for the week so did not have a chance to comment much on Q1 or the shareholder meeting.
I will also second the comments left by MountainDad and Chilar - It was nice finally meeting you both in person and will definitely be there again next year!
As for my comments about how it went - the actual meeting was short and sweet as expected with votes pretty much unanimous for the naming of directors and auditing firm. We did get the chance to catch up with both the CFO (Brian) and CEO (Mark) afterward and to MrD's inquiry on the more superficial aspects and thoughts about personalities... I came out of the meeting and chats with management with a strong confidence that 3Pea is guided by very competent individuals. Management recognizes the potential they have with this firm and have been very strategic about finding board members that have the abilities and the network to take this firm to the next level. I am especially proud that Mark opted to make Dan Henry the Chairman of the board. From my experience with other firms, the best CEO's are the one's that recognize they cannot do everything but have the ability to hire/find people they can leverage to help bolster the bench strength of the Company's management team.
This is not mandatory for NASDAQ uplisting but it is typically a good practice as firms grow to separate the role of CEO and Chairman. Dan's experience founding Euronet Worldwide and as ex-ceo of Netspend will surely be exceptionally additive to 3Pea and growing the Company going forward.
Hold on Tight - the future looks bright for 3Pea!
E.
I don't think we should get our hopes up too much for Q1.
It's typically the weaker quarter and plus they just hired alot of new people which will hit the bottom line but I think revenues might impress and we may have a pretty rosy forward outlook.
doesn't look like it was 50K dumped.. all smaller trades, was just such a big bid-ask spread that when someone hit the low bid it dropped.
here's the trade data:
TRADE DATA
DATE TIMESTAMP PRICE VOLUME TICK DIRECTION CHANGE
05/10/2018 12:58:39 1.395 100 -0.10
05/10/2018 12:23:09 1.49 150 0.38
05/10/2018 12:22:58 1.11 6,750 -0.05
05/10/2018 12:22:53 1.16 1,050 -0.01
05/10/2018 12:22:51 1.17 1,000 -0.01
05/10/2018 12:22:51 1.18 1,000 -0.01
05/10/2018 12:22:51 1.19 100 0.00
05/10/2018 12:22:46 1.19 1,000 -0.11
05/10/2018 12:22:46 1.30 5,000 -0.02
05/10/2018 12:22:28 1.32 1,260